Keywords: fda, extends, review, time, stelara, months, food

FDA extends review time for J&J's Stelara by three months

Article | 27 May 2009

Print This

The US Food and Drug Administration has extended by three months the review timeline for the Biologic License Application for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in